Arman Qamar: Can Ischemic Stroke Polygenic Risk Scores Predict Recurrent Events After Coronary Revascularization?
Arman Qamar, Interventional Cardiologist NorthShore University HealthSystem, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in European Journal of Preventive Cardiology, adding:
”Excited to share our latest publication in the European Journal of Preventive Cardiology: ‘Ischemic Stroke Polygenic Risk Score and Recurrent Cardiac and Cerebrovascular Events After Coronary Artery Revascularization’
In this study, we explored whether ischemic stroke polygenic risk scores can help identify patients at higher risk for recurrent cardiovascular and cerebrovascular events following coronary revascularization.
As cardiovascular care continues moving toward precision medicine, integrating genetic risk with traditional clinical assessment may improve long-term risk stratification and secondary prevention strategies.
Grateful to our outstanding co-authors and collaborators who contributed to this work.
Looking forward to future efforts bridging genomics, outcomes research, and personalized cardiovascular care.”
Title: Ischaemic stroke polygenic risk score and recurrent cardiac and cerebrovascular events after coronary artery revascularization Get access Arrow
Authors: Aman Goyal, Zhuqing Shi, Humza Saeed, Samir Kapadia, Krishna G Aragam, Jianfeng Xu, Arman Qamar

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series